START UPS

Lavish parties were thrown, expensive offices leased and superfluous employees hired as US funds poured cheap money into startups, without due diligence. Now the party is over.

The funds have been raised from Israeli institutional investors including banks, insurance companies and investment houses.

The US venture capital firm, which has extensive Israeli investments, has told startups to increase revenue and profits at the expense of market expansion.

The Israeli company, which provides a cryptographic compression service, has quadrupled its valuation in the past six months.

Neuralight seeks to improve the design of neurological clinical trials, increase the probability of success for novel neurological therapeutics, as part of a new era of precision medicine for neurology.

The price is $60 million. PubPlus CEO Gil Bar-Tur: This is the first of five planned acquisitions by ClearPier, aimed at turning it into a public company.

The Israeli-US company has developed product functionalities to help data teams achieve more reliable data.

As changed market conditions bite, the era that hallowed technology is giving way to an era that's meaner and less patient.

The Israeli-US company enables enterprises to significantly speed up the amount of time required to recover from a cyberattack.

The Israeli company uses AI and big-data to improve IVF outcomes with technology that allows accurate and early, data-driven embryo quality assessment.

From populations missing out to low government investment, the Innovation Authority finds causes for concern about the economy's main engine.

The Israeli enterprise AI solutions startup is closing after advanced talks to sell the company to a tech giant broke down, CEO Roey Mechrez told "Globes."

Israeli company Olive Diagnostics has developed a toilet-mounted sensor to analyze urine and detect illnesses ranging from kidney stones to cancer.

The Israeli startup provides a business model, in which students only pay for courses, in monthly installments from their salary, if they are placed in a tech job.

The raise, led by Target Global, is an extension of the company's seed round in which it raised $13 million last November.

The Israeli-US embedded finance company closed the round before the valuation bubble began to burst.

The company, founded in 2019, reports revenue already running at $42 million annually, and doubling every quarter.

Most of the company's employees in Israel are being laid off, while US operations are being cut back.

Co-founder and CEO Amos Haggiag: It wasn't easy to get the valuation we wanted.

Agassi is executive chairperson of LiDAR developer Makalu Optics of Rehovot.

CyberArk Ventures has made three initial investments in cybersecurity startups.

The Israeli company has developed a data platform connecting physical merchandise to the cloud.

The Israeli company's precision oncology diagnostic solution is expected to launch commercially in the US in the third quarter of 2022.

proteanTecs provides advanced cloud and edge enterprise solutions that monitor the health and performance of electronics to help customers scale their operations.

YL Ventures has raised its largest ever fund despite admitting that the startup financing market is in a slowdown.

The two Israeli companies will combine to provide an AI-driven view into the diverse factors that influence overall production health.

Cellwize deals in cellular network optimization. The acquisition price is estimated to be in the low hundreds of millions of dollars.

The Israeli company has developed the RENOVA iStim implantable tibial neuromodulation device under investigation for the treatment of incontinence and overactive bladder (OAB).

The Israeli company's platform delivers data-driven insights for faster, more intelligent decisions, by providing instant access to any data, enabling an organization-wide approach to business intelligence and analytics.

Plus Ventures and Oren Abekasis allege in the Tel Aviv court that Lusha's app was copied from a previous venture owned by the same entrepreneur, in which they had invested. Lusha denies any connection.